113 related articles for article (PubMed ID: 38623967)
41. CCAT1 promotes triple-negative breast cancer progression by suppressing miR-218/ZFX signaling.
Han C; Li X; Fan Q; Liu G; Yin J
Aging (Albany NY); 2019 Jul; 11(14):4858-4875. PubMed ID: 31310241
[TBL] [Abstract][Full Text] [Related]
42. Ribociclib (LEE011) suppresses cell proliferation and induces apoptosis of MDA-MB-231 by inhibiting CDK4/6-cyclin D-Rb-E2F pathway.
Li T; Xiong Y; Wang Q; Chen F; Zeng Y; Yu X; Wang Y; Zhou F; Zhou Y
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):4001-4011. PubMed ID: 31588803
[TBL] [Abstract][Full Text] [Related]
43. GLIS Family Zinc Finger 3 Promotes Triple-Negative Breast Cancer Progression by Inducing Cell Proliferation, Migration and Invasion, and Activating the NF-κB Signaling Pathway.
Li C; Geng C
Biol Pharm Bull; 2023; 46(2):209-218. PubMed ID: 36724950
[TBL] [Abstract][Full Text] [Related]
44. Proliferation-associated long noncoding RNA, TMPO-AS1, is a potential therapeutic target for triple-negative breast cancer.
Mitobe Y; Ikeda K; Sato W; Kodama Y; Naito M; Gotoh N; Miyata K; Kataoka K; Sasaki H; Horie-Inoue K; Inoue S
Cancer Sci; 2020 Jul; 111(7):2440-2450. PubMed ID: 32437068
[TBL] [Abstract][Full Text] [Related]
45. Non-SMC Condensin I Complex Subunit D2 Is a Prognostic Factor in Triple-Negative Breast Cancer for the Ability to Promote Cell Cycle and Enhance Invasion.
Zhang Y; Liu F; Zhang C; Ren M; Kuang M; Xiao T; Di X; Feng L; Fu L; Cheng S
Am J Pathol; 2020 Jan; 190(1):37-47. PubMed ID: 31610177
[TBL] [Abstract][Full Text] [Related]
46. Teriflunomide, an immunomodulatory drug, exerts anticancer activity in triple negative breast cancer cells.
Huang O; Zhang W; Zhi Q; Xue X; Liu H; Shen D; Geng M; Xie Z; Jiang M
Exp Biol Med (Maywood); 2015 Apr; 240(4):426-37. PubMed ID: 25304315
[TBL] [Abstract][Full Text] [Related]
47. Extracellular matrix marker LAMC2 targets ZEB1 to promote TNBC malignancy via up-regulating CD44/STAT3 signaling pathway.
Wang D; Keyoumu K; Yu R; Wen D; Jiang H; Liu X; Di X; Zhang S
Mol Med; 2024 May; 30(1):61. PubMed ID: 38760717
[TBL] [Abstract][Full Text] [Related]
48. Tumor-derived exosomal circPSMA1 facilitates the tumorigenesis, metastasis, and migration in triple-negative breast cancer (TNBC) through miR-637/Akt1/β-catenin (cyclin D1) axis.
Yang SJ; Wang DD; Zhong SL; Chen WQ; Wang FL; Zhang J; Xu WX; Xu D; Zhang Q; Li J; Zhang HD; Hou JC; Mao L; Tang JH
Cell Death Dis; 2021 Apr; 12(5):420. PubMed ID: 33911067
[TBL] [Abstract][Full Text] [Related]
49. LncRNA T376626 is a promising serum biomarker and promotes proliferation, migration, and invasion via binding to LAMC2 in triple-negative breast cancer.
He Y; Xiao B; Lei T; Xuan J; Zhu Y; Kuang Z; Liu J; He J; Li L; Sun Z
Gene; 2023 Apr; 860():147227. PubMed ID: 36709879
[TBL] [Abstract][Full Text] [Related]
50. Circ-TFCP2L1 Promotes the Proliferation and Migration of Triple Negative Breast Cancer through Sponging miR-7 by Inhibiting PAK1.
Wang Q; Li Z; Hu Y; Zheng W; Tang W; Zhai C; Gu Z; Tao J; Wang H
J Mammary Gland Biol Neoplasia; 2019 Dec; 24(4):323-331. PubMed ID: 31776835
[TBL] [Abstract][Full Text] [Related]
51. Platinum complexes inhibit HER-2 enriched and triple-negative breast cancer cells metabolism to suppress growth, stemness and migration by targeting PKM/LDHA and CCND1/BCL2/ATG3 signaling pathways.
Bai X; Ali A; Lv Z; Wang N; Zhao X; Hao H; Zhang Y; Rahman FU
Eur J Med Chem; 2021 Nov; 224():113689. PubMed ID: 34293698
[TBL] [Abstract][Full Text] [Related]
52. Constructing a novel prognostic model for triple-negative breast cancer based on genes associated with vasculogenic mimicry.
Ren Y; Feng L; Tan Z; Zhou F; Liu S
Aging (Albany NY); 2024 May; 16(9):8086-8109. PubMed ID: 38728245
[TBL] [Abstract][Full Text] [Related]
53. High expression of FUSE binding protein 1 in breast cancer stimulates cell proliferation and diminishes drug sensitivity.
Liu W; Xiong X; Chen W; Li X; Hua X; Liu Z; Zhang Z
Int J Oncol; 2020 Aug; 57(2):488-499. PubMed ID: 32626933
[TBL] [Abstract][Full Text] [Related]
54. LncRNA FAM83H-AS1 promotes triple-negative breast cancer progression by regulating the miR-136-5p/metadherin axis.
Han C; Fu Y; Zeng N; Yin J; Li Q
Aging (Albany NY); 2020 Feb; 12(4):3594-3616. PubMed ID: 32074085
[TBL] [Abstract][Full Text] [Related]
55. Upregulation of MGP by HOXC8 promotes the proliferation, migration, and EMT processes of triple-negative breast cancer.
Gong C; Zou J; Zhang M; Zhang J; Xu S; Zhu S; Yang M; Li D; Wang Y; Shi J; Li Y
Mol Carcinog; 2019 Oct; 58(10):1863-1875. PubMed ID: 31264274
[TBL] [Abstract][Full Text] [Related]
56. Metabotropic glutamate receptor-1 contributes to progression in triple negative breast cancer.
Banda M; Speyer CL; Semma SN; Osuala KO; Kounalakis N; Torres Torres KE; Barnard NJ; Kim HJ; Sloane BF; Miller FR; Goydos JS; Gorski DH
PLoS One; 2014; 9(1):e81126. PubMed ID: 24404125
[TBL] [Abstract][Full Text] [Related]
57. Anti-tumor and anti-metastasis efficacy of E6201, a MEK1 inhibitor, in preclinical models of triple-negative breast cancer.
Lee J; Lim B; Pearson T; Choi K; Fuson JA; Bartholomeusz C; Paradiso LJ; Myers T; Tripathy D; Ueno NT
Breast Cancer Res Treat; 2019 Jun; 175(2):339-351. PubMed ID: 30826934
[TBL] [Abstract][Full Text] [Related]
58. Targeting PI3K and AMPKα Signaling Alone or in Combination to Enhance Radiosensitivity of Triple Negative Breast Cancer.
Johnson J; Chow Z; Napier D; Lee E; Weiss HL; Evers BM; Rychahou P
Cells; 2020 May; 9(5):. PubMed ID: 32438621
[TBL] [Abstract][Full Text] [Related]
59. miR-720 is a downstream target of an ADAM8-induced ERK signaling cascade that promotes the migratory and invasive phenotype of triple-negative breast cancer cells.
Das SG; Romagnoli M; Mineva ND; Barillé-Nion S; Jézéquel P; Campone M; Sonenshein GE
Breast Cancer Res; 2016 Apr; 18(1):40. PubMed ID: 27039296
[TBL] [Abstract][Full Text] [Related]
60. Inhibition of SK4 Potassium Channels Suppresses Cell Proliferation, Migration and the Epithelial-Mesenchymal Transition in Triple-Negative Breast Cancer Cells.
Zhang P; Yang X; Yin Q; Yi J; Shen W; Zhao L; Zhu Z; Liu J
PLoS One; 2016; 11(4):e0154471. PubMed ID: 27124117
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
